16-hydroxydehydroepiandrosterone profile

16-hydroxydehydroepiandrosterone (16-OH-DHEA) is a naturally occurring steroid hormone that is a derivative of dehydroepiandrosterone (DHEA). It is synthesized in the adrenal glands, and its levels decline with age. Research suggests that 16-OH-DHEA may have a variety of effects on the body, including potential neuroprotective, anti-inflammatory, and antioxidant properties. It has been studied for its potential role in cognitive function, mood regulation, and aging. Studies have investigated its effects on memory, learning, and overall brain health. 16-OH-DHEA's role in promoting healthy aging and mitigating age-related decline is an active area of research.'

16-hydroxydehydroepiandrosterone: RN refers to (3beta,16alpha)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ID Source	ID
PubMed CID	102030
CHEMBL ID	2057645
CHEBI ID	27771
SCHEMBL ID	2504654
MeSH ID	M0057456

Synonym
3beta,16alpha-dihydroxy-5-androsten-17-one
LMST02020064
5-androstene-3beta,16alpha-diol-17-one
16alpha-hydroxydehydroepiandrosterone
C05139
1232-73-1
16alpha-hydroxydehydroisoandrosterone
CHEBI:27771 ,
3beta,16alpha-dihydroxyandrost-5-en-17-one
3beta,16alpha-dihydroxy-androst-5-en-17-one
(3s,8r,9s,10r,13s,14s,16r)-3,16-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one
bdbm50388516
unii-wu2du6ga72
wu2du6ga72 ,
16-hydroxydehydroepiandrosterone
(3beta,16alpha)-3,16-dihydroxyandrost-5-en-17-one
3beta,16beta-dihydroxyandrost-5-en-17-one
CHEMBL2057645 ,
SCHEMBL2504654
3,16-dihydroxyandrost-5-en-17-one #
QQIVKFZWLZJXJT-DNKQKWOHSA-N
androst-5-en-17-one, 3,16-dihydroxy-, (3.beta.,16.alpha.)-
DTXSID90153892
16alpha-hydroxy-dhea
3ss,16a-dihydroxy-androst-5-en-17-on
3b,16a-dihydroxyandrost-5-en-17-one
androst-5-ene-3b-16a-diol-17-one
16a-hydroxydehydroandrosterone
3b,16a-dihydroxy-androst-5-en-17-one
16a-hydroxydehydroepiandrosterone
16-hydroxydehydroandrosterone
16 alpha-hydroxy-dehydroepiandrosterone
16a-hydroxy-dhea
Q4551082
16.alpha.-hydroxydehydroepiandrosterone
16.alpha.-hydroxy-dhea
(3.beta.,16.alpha.)-3,16-dihydroxyandrost-5-en-17-one
PD150788
AKOS040755522
16??-hydroxy dehydroepiandrosterone

Role	Description
human metabolite	Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
mouse metabolite	Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Class	Description
16alpha-hydroxy steroid	A 16-hydroxy steroid in which the hydroxy group at position 16 has alpha-configuration.
17-oxo steroid	Any oxo steroid carrying the oxo group at position 17.
androstanoid	Any steroid based on an androstane skeleton and its derivatives.
3beta-hydroxy-Delta(5)-steroid	Any 3beta-hydroxy-steroid that contains a double bond between positions 5 and 6.
secondary alpha-hydroxy ketone	An alpha-hydroxy ketone in which the carbonyl group and the hydroxy group are linked by a carbon bearing one hydrogen and one organyl group. Secondary alpha-hydroxy ketones are also known as acyloins, and are formally derived from reductive coupling of two carboxylic acid groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathway	Proteins	Compounds
Biochemical pathways: part I	0	466

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)	IC50 (µMol)	15.8000	5.1800	7.3200	9.4000	AID672987
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Process	via Protein(s)	Taxonomy
pentose-phosphate shunt	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
lipid metabolic process	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
cholesterol biosynthetic process	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
NADP metabolic process	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
NADPH regeneration	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
glutathione metabolic process	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
pentose-phosphate shunt, oxidative branch	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
response to iron(III) ion	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
negative regulation of protein glutathionylation	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
response to organic cyclic compound	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
pentose biosynthetic process	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
substantia nigra development	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
response to food	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
cellular response to oxidative stress	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
erythrocyte maturation	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
regulation of neuron apoptotic process	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
response to ethanol	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
ribose phosphate biosynthetic process	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
glucose 6-phosphate metabolic process	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
negative regulation of cell growth involved in cardiac muscle cell development	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
negative regulation of reactive oxygen species metabolic process	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
glucose metabolic process	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Process	via Protein(s)	Taxonomy
glucose-6-phosphate dehydrogenase activity	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
protein binding	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
glucose binding	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
identical protein binding	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
protein homodimerization activity	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
NADP binding	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Process	via Protein(s)	Taxonomy
cytoplasm	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
cytosol	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
cytoplasmic side of plasma membrane	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
membrane	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
centriolar satellite	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
intracellular membrane-bounded organelle	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
extracellular exosome	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
cytosol	Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Assay ID	Title	Year	Journal	Article
AID672987	Inhibition of human recombinant N-terminal His tagged G6PD expressed in Escherichia coli JM109 (DE3) cells assessed as production of NADPH after 30 mins by Amplite fluorimetric assay	2012	Journal of medicinal chemistry, May-10, Volume: 55, Issue:9	Novel steroid inhibitors of glucose 6-phosphate dehydrogenase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	20 (58.82)	18.7374
1990's	3 (8.82)	18.2507
2000's	5 (14.71)	29.6817
2010's	5 (14.71)	24.3611
2020's	1 (2.94)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	1 (2.86%)	5.53%
Reviews	1 (2.86%)	6.00%
Case Studies	2 (5.71%)	4.05%
Observational	0 (0.00%)	0.25%
Other	31 (88.57%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Trials	Classes	Roles
chlorine chloride : A halide anion formed when chlorine picks up an electron to form an an anion.	2.02	1	0	halide anion; monoatomic chlorine	cofactor; Escherichia coli metabolite; human metabolite
corticosterone [no description available]	1.96	1	0	11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone	human metabolite; mouse metabolite
estriol hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone. chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.	3.57	9	0	16alpha-hydroxy steroid; 17beta-hydroxy steroid; 3-hydroxy steroid	estrogen; human metabolite; human xenobiotic metabolite; mouse metabolite
estrone Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.	2.68	3	0	17-oxo steroid; 3-hydroxy steroid; phenolic steroid; phenols	antineoplastic agent; bone density conservation agent; estrogen; human metabolite; mouse metabolite
androsterone [no description available]	2.07	1	0	17-oxo steroid; 3alpha-hydroxy steroid; androstanoid; C19-steroid	androgen; anticonvulsant; human blood serum metabolite; human metabolite; human urinary metabolite; mouse metabolite; pheromone
dehydroepiandrosterone Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.. dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.	7.32	34	1	17-oxo steroid; 3beta-hydroxy-Delta(5)-steroid; androstanoid	androgen; human metabolite; mouse metabolite
androstenedione Androstenedione: A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL.. androst-4-ene-3,17-dione : A 3-oxo Delta(4)-steroid that is androst-4-ene substituted by oxo groups at positions 3 and 17. It is a steroid hormone synthesized in the adrenal glands and gonads.	2.06	1	0	17-oxo steroid; 3-oxo-Delta(4) steroid; androstanoid	androgen; Daphnia magna metabolite; human metabolite; mouse metabolite
pregnenolone [no description available]	2.89	4	0	20-oxo steroid; 3beta-hydroxy-Delta(5)-steroid; C21-steroid	human metabolite; mouse metabolite
androstenediol Androstenediol: An intermediate in TESTOSTERONE biosynthesis, found in the TESTIS or the ADRENAL GLANDS. Androstenediol, derived from DEHYDROEPIANDROSTERONE by the reduction of the 17-keto group (17-HYDROXYSTEROID DEHYDROGENASES), is converted to TESTOSTERONE by the oxidation of the 3-beta hydroxyl group to a 3-keto group (3-HYDROXYSTEROID DEHYDROGENASES).. androst-5-ene-3beta,17beta-diol : A 3beta-hydroxy-Delta(5)-steroid that is 3beta-hydroxyandrost-5-ene carrying an additional hydroxy group at position 17beta.	4.05	4	0	17beta-hydroxy steroid; 3beta-hydroxy-Delta(5)-steroid	androgen; human metabolite; mouse metabolite; radiation protective agent
dehydroepiandrosterone sulfate Dehydroepiandrosterone Sulfate: The circulating form of a major C19 steroid produced primarily by the ADRENAL CORTEX. DHEA sulfate serves as a precursor for TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE.. dehydroepiandrosterone sulfate : A steroid sulfate that is the 3-sulfooxy derivative of dehydroepiandrosterone.	2.37	2	0	17-oxo steroid; steroid sulfate	EC 2.7.1.33 (pantothenate kinase) inhibitor; human metabolite; mouse metabolite
cerium Cerium: An element of the rare earth family of metals. It has the atomic symbol Ce, atomic number 58, and atomic weight 140.12. Cerium is a malleable metal used in industrial applications.	2.02	1	0	f-block element atom; lanthanoid atom
pregnanolone Pregnanolone: A pregnane found in the urine of pregnant women and sows. It has anesthetic, hypnotic, and sedative properties.. 3alpha-hydroxy-5beta-pregnan-20-one : The 3alpha-stereoisomer of 3-hydroxy-5beta-pregnan-20-one.	2.31	1	0	3-hydroxy-5beta-pregnan-20-one; 3alpha-hydroxy steroid	human metabolite; intravenous anaesthetic; sedative
16-bromoepiandrosterone 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-one: a synthetic adrenal hormone that reduced the incidence of tuberculosis and other opportunistic infections in AIDS patients	2.07	1	0
17-alpha-hydroxypregnenolone 17-alpha-Hydroxypregnenolone: A 21-carbon steroid that is converted from PREGNENOLONE by STEROID 17-ALPHA-HYDROXYLASE. It is an intermediate in the delta-5 pathway of biosynthesis of GONADAL STEROID HORMONES and the adrenal CORTICOSTEROIDS.. 17alpha-hydroxypregnenolone : A hydroxypregnenolone carrying an alpha-hydroxy group at position 17.	4.73	7	1	17alpha-hydroxy-C21-steroid; 17alpha-hydroxy steroid; 3beta-hydroxy-Delta(5)-steroid; hydroxypregnenolone; tertiary alpha-hydroxy ketone	human metabolite; mouse metabolite
brexanolone brexanolone: a mixture of allopregnanolone and sulfobutylether‐beta‐cyclodextrin for treatment of postpartum depression. brexanolone : A 3-hydroxy-5alpha-pregnan-20-one in which the hydroxy group at position 3 has alpha-configuration. It is a metabolite of the sex hormone progesterone and used for the treatment of postpartum depression in women.	2.07	1	0	3-hydroxy-5alpha-pregnan-20-one	antidepressant; GABA modulator; human metabolite; intravenous anaesthetic; sedative
tetrahydrodeoxycorticosterone tetrahydrodeoxycorticosterone: RN given refers to (3alpha,5beta)-isomer	2.07	1	0	21-hydroxy steroid
16-hydroxyestrone 16-hydroxyestrone: has implications in estrogen physiology & pathophysiology; RN given refers to parent cpd; structure in Negwer, 5th ed, #3670	1.96	1	0
16-hydroxydehydroepiandrosterone sulfate 16-hydroxydehydroepiandrosterone sulfate: RN given refers to cpd with unspecified sulfate ester linkage locant & (3 beta,16 beta)-isomer	1.96	1	0
cortisone [no description available]	1.96	1	0	11-oxo steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	human metabolite; mouse metabolite
21-hydroxypregnenolone 21-hydroxypregnenolone: RN given refers to (3beta)-isomer;. 21-hydroxypregnenolone : A hydroxypregnenolone that is pregnenolone which has been substituted by a hydroxy group at position 21.	2.07	1	0	21-hydroxy steroid; hydroxypregnenolone; primary alpha-hydroxy ketone	mouse metabolite
2-hydroxyestrone 2-hydroxyestrone: catechol estrogen which is a major metabolite of estradiol in man & animals; RN given refers to parent cpd. 2-hydroxyestrone : A 2-hydroxy steroid that is estrone substituted by a hydroxy group at position 2.	2.06	1	0	2-hydroxy steroid; catechols	human metabolite
epiandrosterone epiandrosterone : A 3beta-hydroxy steroid that is (5alpha)-androstane substituted by a beta-hydroxy group at position 3 and an oxo group at position 17.	2.07	1	0	17-oxo steroid; 3beta-hydroxy steroid; androstanoid	androgen; human metabolite
sodium borohydride sodium borohydride: RN given refers to parent cpd	2.02	1	0	inorganic sodium salt; metal tetrahydridoborate
pregnanediol [no description available]	2.38	2	0
5-androstene-3,16,17-triol 5-androstene-3,16,17-triol: structure	2.66	3	0	3-hydroxy steroid	androgen
nitrophenols Nitrophenols: PHENOLS carrying nitro group substituents.	1.95	1	0

Condition	Relationship Strength	Studies
Hyperoxia An abnormal increase in the amount of oxygen in the tissues and organs.	2.15	1
Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.	4.04	15
Carcinoma, Papillary A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)	2.06	1
Cancer of the Thyroid [description not available]	2.06	1
Thyroid Neoplasms Tumors or cancer of the THYROID GLAND.	2.06	1
Cancer of Prostate [description not available]	2.94	1
Prostatic Neoplasms Tumors or cancer of the PROSTATE.	2.94	1
Infantile Respiratory Distress Syndrome [description not available]	2.03	1
Respiratory Distress Syndrome, Newborn A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.	2.03	1
Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)	2.03	1
Birth Weight The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.	1.96	1
Xeroderma [description not available]	1.96	1
Ichthyosis Any of several generalized skin disorders characterized by dryness, roughness, and scaliness, due to hypertrophy of the stratum corneum epidermis. Most are genetic, but some are acquired, developing in association with other systemic disease or genetic syndrome.	1.96	1
Fetal Growth Restriction [description not available]	1.95	1
Fetal Growth Retardation Failure of a FETUS to attain expected GROWTH.	1.95	1
Blood Pressure, High [description not available]	2.64	3
Cardiovascular Pregnancy Complications [description not available]	1.96	1
Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.	2.64	3
Absence of Brain, Congenital [description not available]	1.96	1
Fetal Death Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH.	1.96	1
Fetal Distress A nonreassuring fetal status (NRFS) indicating that the FETUS is compromised (American College of Obstetricians and Gynecologists 1988). It can be identified by sub-optimal values in FETAL HEART RATE; oxygenation of FETAL BLOOD; and other parameters.	1.96	1
Cirrhosis, Liver [description not available]	1.95	1
Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.	1.95	1
Placenta Diseases Pathological processes or abnormal functions of the PLACENTA.	1.95	1
Adenoma, Basal Cell [description not available]	1.95	1
Adrenal Cancer [description not available]	1.95	1
Androgenization [description not available]	1.95	1
Adenoma A benign epithelial tumor with a glandular organization.	1.95	1
Cushing's Syndrome [description not available]	1.95	1
Edema-Proteinuria-Hypertension Gestosis [description not available]	1.95	1
Adrenal Gland Diseases Pathological processes of the ADRENAL GLANDS.	1.95	1
Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.	1.95	1
Pre-Eclampsia A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.	1.95	1
Choriocarcinoma A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL).	1.96	1

16-hydroxydehydroepiandrosterone

Description

Cross-References

Synonyms (40)

Roles (2)

Drug Classes (5)

Pathways (1)

Protein Targets (1)

Inhibition Measurements

Biological Processes (23)

Molecular Functions (6)

Ceullar Components (7)

Bioassays (1)

Research

Studies (34)

Market Indicators

Research Demand Index: 10.93

Study Types